Jeff Shuren on the toils of COVID; An expert panel discusses medtech’s post-COVID rebound; 2020 was a record year for FDA device approvals; Scott Gottlieb on the pandemic’s effect on HealthTech innovation. Excerpts from the latest coronavirus analysis in MedTech Strategist and Market Pathways.Read Article
20 Years of Experience
@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.